Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following

NCT02783404 is registered in ClinicalTrials.gov with University of Santiago de Compostela as lead sponsor.

NCT NCT02783404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02783404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Oral Amoxicillin-Clavulanate Regimen to Prevent Bacteremia Following
Lead sponsor
University of Santiago de Compostela
Phase
Phase 4
Overall status
Terminated
Start date
February 27, 2017
Completion date
May 17, 2022
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacteraemia, endocarditis